Don't Eat the Marshmallow! 4 Tips for Financial Self-Control
Get the Lead Out: Lipsticks That Won't Hurt Your Pocketbook Or Your Health
$600 Million Powerball: 1 Winning Ticket Sold in Fla.
GM Shares Top Level Not Seen Since 2011
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
PharmaDirections is Co-inventor on Second Issued Formulation Patent Entitled “Layered Pharmaceutical Formulations”
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Orexigen, Vivus remain in weight-loss limbo
Orexigen Therapeutics' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Orexigen reports Q1 EPS (21c), consensus (34c)
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
Is Orexigen Therapeutics Burning Too Much Cash?